Rx/Reimbursement Adult Incontinence in Belgium

Rx/Reimbursement Adult Incontinence in Belgium

Demand increased during 2022, with a couple of key drivers behind this growth. Firstly, the country's ageing population continued to drive ongoing demand for RX/reimbursement adult incontinence. In addition, the demand for reimbursement for adult incontinence increased due to the high inflation and the financial turmoil experience by some Belgians in 2022. On June 1st, 2022, the reimbursement amount was increased due to inflation. The allocation is now EUR177.24 for non-dependent and EUR543.02 f...

Euromonitor International's Rx/Reimbursement adult incontinence in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2027 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.